Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...

A groundbreaking lung cancer vaccine will be tested on humans from summer 2026, with British scientists working on jabs for ...

At the Cleveland Clinic, researchers are testing a preventive breast cancer vaccine, and results from Phase 1 of the trial are showing promising signs.

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the cancer from recurring or possibly prevent it entirely.

An analysis of ongoing trials suggests that mRNA cancer vaccines have the potential to deliver health benefits worth $75 ...

The trial targeting triple-negative breast cancer, which disproportionately affects Black women, induced immune responses in ...

A recent breast cancer vaccine brings good news for women. The jab could help prevent Triple-negative breast cancer (TNBC) before it starts. Plus, it could reduce harsh treatments, empower high-risk ...

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine.

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

Last August, Labroots covered the decision of the National Health Service of England (NHS England) to allow subcutaneous (under the skin) injections of programmed death ligand 1 (PD-L1) blocker called ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...